Search results for "Depressive disorder"

showing 10 items of 445 documents

Effects of Multidomain Risk Accumulation on Cognitive, Academic, and Behavioural Outcomes

2009

This longitudinal study examined the predictive associations between cumulative multidomain risk factors and cognitive (IQ), academic (reading fluency), and social adaptive outcomes at 8 to 9 years among 190 children with or without familial risk for dyslexia. Other risk factors included parental and neurocognitive risks assessed when the children were 1 to 6 years of age. Risks accumulated more among children with familial risk for dyslexia than among children without familial risk. A higher number of risks was associated with poorer performance in all outcome measures as postulated by the cumulative risk model. However, when the effects of individual risk variables were controlled for at …

MaleLongitudinal studyMothersChild Behavior DisordersAcademic achievementNeuropsychological TestsSeverity of Illness IndexDevelopmental psychologyRisk FactorsSeverity of illnessDevelopmental and Educational PsychologymedicineCognitive developmentHumansChildDepressive DisorderIntelligence quotientDyslexiaCognitionAchievementmedicine.diseaseClinical PsychologyFemaleCognition DisordersPsychologySocial AdjustmentNeurocognitiveChild LanguageClinical psychologyJournal of Clinical Child & Adolescent Psychology
researchProduct

Sensitivity to change of two depression rating scales for stroke patients.

2010

Objective: To assess the sensitivity to change of two depression scales for stroke patients: the Aphasic Depression Rating Scale (ADRS), which is a 9-item external assessment, and the Visual Analog Mood Scale (VAMS), which is a visual self-assessment scale. Patients: Forty-nine stroke patients admitted to two rehabilitation units. Methods: Symptoms of depression were assessed twice at a one-month interval (D0—D30) using the ADRS, the VAMS, and by a trained psychologist (PSY). Sensitivity to change was assessed by effect size and standardized response mean. A one-way ANOVA on ranks was performed to determine if the scales distinguished between deteriorated, stable and improved patient statu…

MaleMESH: Psychiatric Status Rating ScalesMESH : StrokeStroke patientmedicine.medical_treatmentMESH: Depressive DisorderMESH : AgedMESH : Analysis of VarianceSeverity of Illness IndexMood scale[ SDV.NEU.SC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences0302 clinical medicineMESH : Female030212 general & internal medicineDepression (differential diagnoses)MESH: AgedMESH : AphasiaRehabilitationMESH: Middle AgedRehabilitationStroke Rehabilitation[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesMiddle AgedMESH : AdultStrokeFemaleMESH : Severity of Illness IndexPatient statusMESH : Sensitivity and SpecificityMESH : Psychiatric Status Rating ScalesPsychologyClinical psychologyAdultmedicine.medical_specialtyMESH : MalePhysical Therapy Sports Therapy and RehabilitationSensitivity and SpecificityMESH: Stroke03 medical and health sciencesRating scaleMESH: Severity of Illness IndexMESH: Analysis of VarianceAphasiamedicineHumansMESH : Middle AgedSensitivity to changeAgedMESH: AphasiaPsychiatric Status Rating ScalesAnalysis of VarianceDepressive DisorderMESH: HumansMESH : HumansMESH: AdultMESH: Sensitivity and SpecificityMESH: MaleMESH : Depressive DisorderPhysical therapyMESH: Female030217 neurology & neurosurgery
researchProduct

Depression and obesity, data from a national administrative database study: Geographic evidence for an epidemiological overlap

2019

BackgroundDepression and obesity are two major conditions with both psychological and somatic burdens. Some data suggest strong connections between depression and obesity and more particularly associated prevalence of both disorders. However, little is known about the geographical distribution of these two diseases. This study aimed to determine if there is spatial overlap between obesity and depression using data from the entire French territory.MethodsData for 5,627 geographic codes for metropolitan France were collected from the two national hospital databases (PMSI-MCO and RIM-P) for the year 2016. We identified people who were depressed, obese or both registered in the two public medic…

MaleMultivariate analysisSpatial EpidemiologyDatabases FactualPhysiologyEpidemiology[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthSocial SciencesComorbidityGeographical locationsdépression0302 clinical medicineRuralityRisk FactorsEpidemiologyMedicine and Health SciencesPrevalence030212 general & internal medicineDepression (differential diagnoses)Geographic Areas[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMultidisciplinaryGeographyDepressionQRSpatial epidemiology[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle Aged3. Good healthEuropeSanté publique et épidémiologieobésitéPhysiological ParametersépidémiologieMedicineFemaleFranceResearch ArticleUrban AreasAdultmedicine.medical_specialtyScienceMédecine humaine et pathologiezone rurale030209 endocrinology & metabolismHuman GeographyUrban Geography03 medical and health sciencesMental Health and PsychiatrymedicineHumansObesityEuropean UnionAgedDepressive Disorder Majorbusiness.industryMood DisordersBody WeightBiology and Life Sciencesdéveloppement épidémiologiqueenvironnement urbainmedicine.diseaseObesityComorbidityRural Areaszone urbaine[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthMultivariate AnalysisEarth SciencesHuman health and pathology[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieRural areaPeople and placesbusinessDemographyPLoS ONE
researchProduct

Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study

2018

<b><i>Background:</i></b> No candidate biomarkers based on cerebrospinal fluid (CSF) have been identified as prognostic factors in patients with major depression treated with electroconvulsive therapy (ECT), yet. <b><i>Method:</i></b> Following different underlying hypotheses, we analysed baseline CSF levels of markers of neurodegeneration (tau proteins, β-amyloids and neurogranin), elements of the innate immune system (interleukin [IL]-6, neopterin, soluble CD14, soluble CD163, migration inhibitory factor and monocyte chemotactic protein 1), endocannabinoids, sphingolipids and Klotho before ECT in patients with depression (<i>n</i&gt…

MaleOncologymedicine.medical_treatmentchemistry.chemical_compound0302 clinical medicineCerebrospinal fluidElectroconvulsive therapyNeurogranincerebrospinal fluid [Sphingolipids]Electroconvulsive TherapyKlothoGlucuronidaseAged 80 and overtherapy [Depressive Disorder Major]NeopterinInterleukinMiddle AgedPsychiatry and Mental healthTreatment OutcomeNeuropsychology and Physiological Psychologycerebrospinal fluid [Biomarkers]cerebrospinal fluid [Glucuronidase]Biomarker (medicine)AntidepressantFemaleAdultmedicine.medical_specialtyklotho proteinYoung Adult03 medical and health sciencesInternal medicinemental disordersmedicineHumansddc:610Klotho ProteinsBiological Psychiatrycerebrospinal fluid [Nerve Degeneration]AgedDepressive Disorder MajorSphingolipidsbusiness.industrycerebrospinal fluid [Depressive Disorder Major]Immunity Innate030227 psychiatrychemistryNerve Degenerationcerebrospinal fluid [Endocannabinoids]businessBiomarkers030217 neurology & neurosurgeryEndocannabinoidsNeuropsychobiology
researchProduct

Higher carotid-radial pulse wave velocity is associated with non-melancholic depressive symptoms in men - findings from Helsinki Birth Cohort Study

2021

Background: Depression and cardiovascular disease (CVD) are major causes of global disease burden that are interrelated through mostly unknown mechanisms. We studied the relationship of melancholic and non-melancholic depressive symptoms with arterial stiffness, an important underlying mechanism of CVD. Methods: The Helsinki Birth Cohort Study recruited 683 previously extensively phenotyped subjects for this sub-study. Cross-sectional data along with responses regarding depressive symptoms were obtained for each participant. For evaluation of depressive symptoms, the Beck Depression Inventory (BDI)and subscales were used to measure melancholic and non-melancholic depressive symptoms. Arteri…

MalePediatricsDisease030204 cardiovascular system & hematology3124 Neurology and psychiatryCohort Studies0302 clinical medicinedepressive disorderhemic and lymphatic diseasesMedicine030212 general & internal medicinePulse wave velocitykohorttitutkimusDepression (differential diagnoses)FinlandkomorbiditeettiWave velocityGeneral Medicine3. Good healthcomorbidityCarotid ArteriesPhenotypeCardiovascular DiseasesRadial ArterydepressionFemaleCohort studyCohort studyResearch Articlemasennusmedicine.medical_specialtypulse wave velocityPulse Wave AnalysisRadial pulse03 medical and health sciencesvaltimotSex FactorsVascular Stiffnessmielenterveyshäiriötcohort studyHumansDisease burdenAgedbusiness.industrymedicine.diseaseComorbidityCross-Sectional StudiesGeriatricsHeart Disease Risk Factors3121 General medicine internal medicine and other clinical medicinesydän- ja verisuonitauditoireetbusiness
researchProduct

The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and me…

2016

Background Obstructive sleep apnea (OSA) is a health hazard since it is associated with neurocognitive dysfunction and cardio-metabolic diseases. The prevalence of OSA among people with serious mental illness (SMI) is unclear. Method We searched major electronic databases from inception till 06/2015. Articles were included that reported the prevalence of OSA determined by polysomnography (PSG) or an apnea-hypopnea index (AHI) >5 events/hr, in people with major depressive disorder (MDD), bipolar disorder (BD) or schizophrenia. A random effects meta-analysis calculating the pooled prevalence of OSA and meta-regression of potential moderators were performed. Results Twelve articles were inc…

MalePredictive Value of TestPolysomnographyBody Mass Index0302 clinical medicineRisk FactorsPrevalenceBipolar disorder; Major depressive disorder; Obstructive sleep apnea; Schizophrenia; Serious mental illness; Sleep; Psychiatry and Mental Health; Clinical PsychologySerious mental illneobstructive sleep apneabipolar disorderAged 80 and overSleep Apnea Obstructivemedicine.diagnostic_testMiddle AgedSerious mental illnessObstructive sleep apnea Sleep Serious mental illness Major depressive disorder Bipolar disorder SchizophreniaClinical PsychologySchizophreniaserious mental illnessPsychiatry and Mental HealthPredictive value of testsMeta-analysisMajor depressive disorderPsychologyHumanAdultmedicine.medical_specialtyBipolar disorderPolysomnographyMajor depressive disorder03 medical and health sciencesPredictive Value of TestsInternal medicinemental disordersmedicineHumansBipolar disordersleepAgedDepressive Disorder Majormajor depressive disorderRisk Factormedicine.diseaseObstructive sleep apnea030227 psychiatryrespiratory tract diseasesObstructive sleep apneaschizophreniaPhysical therapySchizophreniaSleepBody mass index030217 neurology & neurosurgery
researchProduct

The Chronic Psychosocial Stress Paradigm in Male Tree Shrews: Evaluation of a Novel Animal Model for Depressive Disorders

2002

To improve our knowledge of the causal mechanisms of stress-related disorders such as depression, we need animal models that mirror the situation in patients. One promising model is the chronic psychosocial stress paradigm in male tree shrews, which is based on the territorial behaviour of these animals that can be used to establish naturally occurring challenging situations under experimental control in the laboratory. Co-existence of two males in visual and olfactory contact leads to a stable dominant-subordinate relationship, with subordinates showing distinct stress-induced behavioural and neuroendocrine alterations that are comparable to the symptoms observed during episodes of depress…

MalePredictive validitymedicine.medical_specialtyClomipraminePhysiologymedicine.drug_classTricyclic antidepressantAntidepressive Agents TricyclicAnxiolyticBehavioral NeurosciencemedicineAnimalsHumansPsychiatryDepression (differential diagnoses)Face validityDepressive DisorderEndocrine and Autonomic SystemsTupaiidaeConstruct validityDisease Models AnimalPsychiatry and Mental healthNeuropsychology and Physiological PsychologyClomipramineEtiologyPsychologyStress Psychologicalmedicine.drugStress
researchProduct

Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin…

2017

AbstractThe aim of this study was to identify molecular pathways related to antidepressant response. We administered paroxetine to the DBA/2J mice for 28 days. Following the treatment, the mice were grouped into responders or non-responders depending on the time they spent immobile in the forced swim test. Hippocampal metabolomics and proteomics analyses revealed that chronic paroxetine treatment affects glutamate-related metabolite and protein levels differentially in the two groups. We found significant differences in the expression of N-methyl-d-aspartate receptor and neuronal nitric oxide synthase proteins between the two groups, without any significant alterations in the respective tra…

MaleProteomics0301 basic medicineProteasome Endopeptidase ComplexGlutamic AcidNitric Oxide Synthase Type IPharmacologyHippocampusReceptors N-Methyl-D-AspartateMice03 medical and health sciencesCellular and Molecular NeuroscienceGlutamatergic0302 clinical medicineUbiquitinmedicineAnimalsHumansMetabolomicsReceptorSwimmingBiological PsychiatryDepressive Disorder MajorbiologyUbiquitinParoxetineAntidepressive AgentsParoxetinePsychiatry and Mental health030104 developmental biologyProteasomeMice Inbred DBALeukocytes Mononuclearbiology.proteinAntidepressantOriginal ArticlePsychopharmacologyPsychology030217 neurology & neurosurgerymedicine.drugBehavioural despair testTranslational Psychiatry
researchProduct

Reduction of depressive symptoms during inpatient treatment is not associated with changes in heart rate variability

2021

Vagally mediated heart rate variability (HRV) is a psychophysiological indicator of mental and physical health. Limited research suggests there is reduced vagal activity and resulting lower HRV in patients with Major Depressive Disorder (MDD); however little is actually known about the association between HRV and symptoms of depression and whether the association mirrors symptom improvement following psychotherapy. The aim of this study was to investigate the association between antidepressant therapy, symptom change and HRV in 50 inpatients (68% females; 17–68 years) with a diagnosis of MDD. Severity of depressive symptoms was assessed by self-report (Beck Depression Inventory II) and the …

MalePsychometricsSocial SciencesCardiovascular MedicineMedical ConditionsHeart RateMedicine and Health SciencesPsychologyMedicineHeart rate variabilityDepression (differential diagnoses)MultidisciplinaryDepressionPharmaceuticsQRDrugsAntidepressantsMiddle AgedAntidepressant Drug TherapyCardiovascular DiseasesMedicineMajor depressive disorderFemaleResearch Articlecirculatory and respiratory physiologyClinical psychologyNeurological Drug TherapyAdultPatientsPsychometricsAdolescentScienceCardiologyYoung AdultDrug Therapy:Medisinske Fag: 700 [VDP]Rating scaleMental Health and PsychiatryHumansIn patientDepressive symptomsAgedPharmacologyInpatientsDepressive Disorder MajorMood Disordersbusiness.industryBeck Depression InventoryBiology and Life Sciencesmedicine.diseaseHealth CarePsychotherapybusinessMental Health Therapies
researchProduct

The deficit syndrome in schizophrenic and nonschizophrenic patients: preliminary studies.

1995

One hundred and eighty-seven patients suffering from DSM-III-R schizophrenia, schizoaffective, schizophreniform (psychotic group), unipolar, bipolar and other disorders were interviewed 5 years after discharge. Deficiencies were assessed by means of the Schedule for Deficit Syndrome (SDS) and the Scale for Assessment of Negative Symptoms (SANS). Binocular thresholds for discomfort to high luminances (TDHL) were assessed in 17 patients with a deficit syndrome. Results suggest that patients with psychotic disorders are in a high-risk group for deficit syndrome. Nevertheless, 9-28% and 9-30% of the 'nonpsychotic' group according to the SANS and the SDS, respectively, showed primary enduring ne…

MalePsychosismedicine.medical_specialtyLightbehavioral disciplines and activitiesSeverity of Illness Indexmental disordersmedicineHumansBipolar disorderPsychiatryDepression (differential diagnoses)Negative symptomChronobiology PhenomenaPsychiatric Status Rating ScalesDepressive DisorderMiddle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologySchizoaffective psychosisStimulus luminancePsychotic DisordersSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyAnxiety disorderPsychopathology
researchProduct